Effective microbiologic spectrum of gyrase inhibitors--indications and contraindications
Abstract
Ciprofloxacin is an essential enrichment of the antibacterial therapy. The activity spectrum comprises enterobacteria, haemophiliacs and Neisseriae, furthermore Legionellae and species of Pseudomonas (except Ps. maltophila). In the gram-positive area staphylococci, Listeriae and corynebacteria are covered, whereas species of streptococci including pneumococci are only moderately sensitive or resistent. Infections of the urinary tract, of the respiratory tract and the biliary tract as well as enteral infections are the main indications. Furthermore, an application in osteomyelitis and arthritis, in chlamydial infections and mycoplasmal infections, in legionellosis and for the selective decontamination in threatening granulocytopenia is justified. Pregnancy, period of growth and cerebral convulsive disorders are contraindications.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.